- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Marconi opens distribution center in Salt Lake
Salt Lake City, a growing high-tech region, is the site of a new 10,000-square-foot Marconi Health Care Products distribution center.The center is one of 30 that Marconi HCP operates in North America, said Larry Miller, division vice president and
Salt Lake City, a growing high-tech region, is the site of a new 10,000-square-foot Marconi Health Care Products distribution center.
The center is one of 30 that Marconi HCP operates in North America, said Larry Miller, division vice president and general manager.
"Salt Lake City is a growing metropolitan area. With the recent launch of our new e-commerce Web site, www.marconihcp.com, customers in this market will enjoy complete supply chain management," Miller said.
Marconi recently won the business of the Intermountain Health Care system, and the new distribution center allows the company to make faster deliveries of online orders with its own fleet of trucks.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
